Covid-19 Vaccines administered to children, young adult and adult
Dear Sir or Madam,
I would like to know the following data from you.
1. The doses (including (1) dosage for each shot, (2) total number of shots, and (3) schedule of vaccination) of Sinovac and BionTech/Pfizer recommended by the Advisory Panel on COVID-19 Vaccines Members to the following age groups:
a. Children aged 3-4
b. Children aged 5-11
c. Children & adolescents aged 12-17
d. Young adults aged 18-30
e. Adults aged 31 or above.
2. Whether the above recommendation made by the Advisory Panel on COVID-19 Vaccines Members are supported and approved in writing by
a. Sinovac
b. BionTech/Pfizer
c. World Health Organization
3. (a) Whether each shot (as to dosage and ingredient) of Sinovac and BionTech/Pfizer COVID 19 vaccine administered to children aged 3-11 is the same as those administered to adult.
(b) If they are not the same, please explain the differences.
Thank you.
Yours faithfully,
Mr Ed Yim
This is to acknowledge receipt of your e-mail. All personal data provided
in your e-mail, if any, will only be used by the Food and Health Bureau
(FHB) for purposes which are directly related to the processing of your
email. Such personal data may be transferred to other Government
departments/bureaux or concerned parties involved in the handling of your
email. Please read our Personal Information Collection Statement
(http://www.fhb.gov.hk/en/contact_us/enqu...) and personal data privacy
protection policy(http://www.fhb.gov.hk/en/notice/privacy....). Regards
Food and Health Bureau HKSAR Government (This message is an auto-reply
generated by the email system) 本局已接獲你的電郵。其內提供的所有個人資料(
如有)，會用於處理你的電郵或直接相關的用途。有關個人資料可能會轉移給其他政
府部門∕政策局或因處理你的電郵而涉及的有關人士或機構。請參閱本局的《收集個
人資料聲明》(http://www.fhb.gov.hk/cn/contact_us/enqu...) 及保障私隱政
策(http://www.fhb.gov.hk/cn/notice/privacy.... 香港特別行政區政府 食物
及衞生局 (此乃電郵系統自動發出的覆函)
Dear Mr Yim ,
The Food and Health Bureau (FHB) has received your application under the
Code on Access to Information on 6 April 2022. Your application is now
under processing.
According to paragraph 1.16 of the Code on Access to Information, you will
be informed of the latest progress of the case separately on or before 27
April 2022.
In the meantime, please contact us by e-mail at [1][Food and Health Bureau request email] if
you have any enquiry. Thank you.
(Ricky LEUNG)
Food and Health Bureau
Dear Mr YIM,
The Food and Health Bureau (FHB) is processing your application under the
Code on Access to Information on 6 April 2022. As we need more time to
collate a reply to your questions, let you have a reply on or before 26
May 2022.
Many thanks for your understanding and sorry for the inconvenience caused.
Should you wish to contact us regarding your enquiries, please feel free
to contact us by e-mail at [1][Food and Health Bureau request email] .
(Ricky LEUNG)
Food and Health Bureau
From: Enquiry FHB/FHB
Sent: Thursday, April 14, 2022 4:26 PM
To: 'Mr Ed Yim' <[2][FOI #1053 email]>
Subject: Re: Freedom of Information request - Covid-19 Vaccines
administered to children, young adult and adult
Dear Mr Yim ,
The Food and Health Bureau (FHB) has received your application under the
Code on Access to Information on 6 April 2022. Your application is now
under processing.
According to paragraph 1.16 of the Code on Access to Information, you will
be informed of the latest progress of the case separately on or before 27
April 2022.
In the meantime, please contact us by e-mail at [3][Food and Health Bureau request email] if
you have any enquiry. Thank you.
(Ricky LEUNG)
Food and Health Bureau
Dear Mr Yim,
I refer to your request for information under the Code on Access to
Information dated 6 April 2022 to the Food and Health Bureau on
authorisation of COVID-19 vaccines by the members of the Advisory Panel on
COVID-19 Vaccines (the Advisory Panel). I am authorised to reply as
follows.
The Government published the Prevention and Control of Disease (Use of
Vaccines) Regulation (Cap. 599K) (the Regulation) in the Gazette on 23
December 2020, which provides the legal framework under the present state
of public health emergency to bring in COVID-19 vaccines which satisfy the
criteria of safety, efficacy and quality for emergency use.
The Regulation empowers the Secretary for Food and Health (SFH) to, based
on the objective clinical data of a COVID-19 vaccine (including third
phase clinical research data), with reference to the expert advice of an
independent advisory panel and having regard to the approval given by a
regulatory authority in a place outside Hong Kong that performs the
function of approving pharmaceutical products (including emergency use),
after being assessed as safe and effective based on science, and with
evidence supporting its quality, authorize and allow the specified use of
the relevant COVID-19 vaccine in Hong Kong under the emergency situation.
For providing advice to the SFH regarding authorization, the Advisory
Panel conducts on-going review of the benefits and risks of authorized
vaccines in order to protect public health. The Advisory Panel conducts
regular meetings to review the latest available evidence and information
related to the safety, efficacy and quality of authorized COVID19
vaccines, and to offer appropriate advice to the SFH in a timely manner.
Ad hoc meetings would also be arranged when it is necessary to conduct an
urgent assessment of the benefit-risk balance of an authorized vaccine.
You may find the brief summary updates on COVID-19 Vaccines endorsed by
Advisory Panel for your reference at
[1]https://www.fhb.gov.hk/en/our_work/healt... .
On the other hand, the Scientific Committee on Vaccine Preventable
Diseases and the Scientific Committee on Emerging and Zoonotic Diseases
(JSC) under the Centre for Health Protection (CHP) of the Department of
Health will convene meetings joined by the Chief Executive's expert
advisory panel to regularly review and update consensus interim
recommendations on use of COVID-19 vaccines in Hong Kong in accordance to
relevant scientific data, overseas practice and recommendations by the
World Health Organization. Details of the interim recommendations are
available at the CHP's website
[2]https://www.chp.gov.hk/en/static/24008.h... .
Thank you again for your attention on vaccination matters.
(Ricky LEUNG)
for Secretary for Food and Health
From: Enquiry FHB/FHB
Sent: Tuesday, May 3, 2022 9:59 AM
To: 'Mr Ed Yim' <[3][FOI #1053 email]>
Subject: Re: Freedom of Information request - Covid-19 Vaccines
administered to children, young adult and adult
Dear Mr YIM,
The Food and Health Bureau (FHB) is processing your application under the
Code on Access to Information on 6 April 2022. As we need more time to
collate a reply to your questions, let you have a reply on or before 26
May 2022.
Many thanks for your understanding and sorry for the inconvenience caused.
Should you wish to contact us regarding your enquiries, please feel free
to contact us by e-mail at [4][Food and Health Bureau request email] .
(Ricky LEUNG)
Food and Health Bureau
From: Enquiry FHB/FHB
Sent: Thursday, April 14, 2022 4:26 PM
To: 'Mr Ed Yim' <[5][FOI #1053 email]>
Subject: Re: Freedom of Information request - Covid-19 Vaccines
administered to children, young adult and adult
Dear Mr Yim ,
The Food and Health Bureau (FHB) has received your application under the
Code on Access to Information on 6 April 2022. Your application is now
under processing.
According to paragraph 1.16 of the Code on Access to Information, you will
be informed of the latest progress of the case separately on or before 27
April 2022.
In the meantime, please contact us by e-mail at [6][Food and Health Bureau request email] if
you have any enquiry. Thank you.
(Ricky LEUNG)
Food and Health Bureau
